Precision Optics Corporation, Inc. (POCI): R&D Expense
$1.16M
Year ended 2025-06-30
$1.06M
Trailing 12 months to 2026-03-31
+20.2%
3-year compound annual growth
+5.5%
5-year compound annual growth
+8.9%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | $1.16M | +17.9% | 2025-09-29, From 2024-07-01 |
| 2024-06-30 | $981.8K | -1.1% | 2025-09-29, From 2023-07-01 |
| 2023-06-30 | $992.4K | +48.9% | 2024-09-30, From 2022-07-01 |
| 2022-06-30 | $666.5K | +6.8% | 2023-09-28, From 2021-07-01 |
| 2021-06-30 | $624.3K | -29.6% | 2022-09-27, From 2020-07-01 |
| 2020-06-30 | $886.1K | +75.4% | 2021-09-28, From 2019-07-01 |
| 2019-06-30 | $505.3K | +10.7% | 2020-09-24, From 2018-07-01 |
| 2018-06-30 | $456.4K | -1.7% | 2019-09-26, From 2017-07-01 |
| 2017-06-30 | $464.2K | -2.9% | 2018-09-27, From 2016-07-01 |
| 2016-06-30 | $478.3K | -3.0% | 2017-09-28, From 2015-07-01 |
| 2015-06-30 | $492.9K | +4.6% | 2016-09-28, From 2014-07-01 |
| 2014-06-30 | $471.1K | -25.3% | 2015-10-13, From 2013-07-01 |
| 2013-06-30 | $630.3K | -5.2% | 2014-09-29, From 2012-07-01 |
| 2012-06-30 | $664.7K | -19.4% | 2013-09-30, From 2011-07-01 |
| 2011-06-30 | $825.0K | n/a | 2012-10-26, From 2010-07-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Precision Optics Corporation, Inc. (POCI) | 2025-06-30 | $1.16M | +17.9% |
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $3.94M | +20.5% |
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $17.45M | -22.4% |
| CapsoVision, Inc (CV) | 2025-12-31 | $18.31M | +21.1% |
| Escalon Medical Corp (ESMC) | 2025-06-30 | $753.1K | +9.4% |
| electroCore, Inc. (ECOR) | 2024-12-31 | $2.36M | -55.6% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $9.38M | -3.9% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $2.71M | -15.5% |
| Iridex Corp (IRIX) | 2026-01-03 | $3.67M | -32.7% |
Compare POCI, QTI, HYPR, CV side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗